Clinical Trial Update: REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs

View source ↗

Summary

The REMBRANDT trial investigates recovery of the oral microbiome after antibiotic exposure in dental implant patients, sponsored by the University of Pennsylvan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Colitis
• Clostridioides Difficile Infection
• Dysbiosis

Snippet

Sponsor: University of Pennsylvania | Conditions: Dysbiosis, Clostridium Difficile | Status: ACTIVE_NOT_RECRUITING